Stock listing
Frankfurt:NK9 Neuren Pharmaceuticals Limited Aktie
German listing (Frankfurt) of Neuren Pharmaceuticals Limited · home listing ASX:NEU
Follow Neuren Pharmaceuticals Limited into a list and get an email when it puts out news.
Share price · FWB:NK9
€12.60 EUR +1.10 (+9.6%)
Close on Oct 30, 2026
- Day range
- €12.60 – €12.60 EUROct 30, 2026
- Market cap
- €1.60B EURAt the close on Oct 30, 2026 · price × 126.8M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:NEU · Home | $20.75 AUD | +0.39 (+1.9%) | 459,852 | $20.36 | $21.48 | $20.03 | $20.36 | Close on Nov 2, 2026 |
| Frankfurt:NK9 | €12.60 EUR | +1.10 (+9.6%) | — | €12.60 | €12.60 | €12.60 | €11.50 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:NK9
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 1, 2026
FDA grants Orphan Drug Designation for NNZ-2591 to treat HIE
Latest deck · Sep 2, 2026
Investor Presentation (September 2026)
Investor deck · 19 slides
Latest news
Decks
Investor Presentation (September 2026)
Investor deck · 19 slides · Sep 2, 2026
H1 2026 Earnings Presentation
Earnings · 15 slides · Aug 26, 2026
Shareholder Meeting (May 2026)
Shareholder meeting · 16 slides · May 27, 2026
Shareholder Meeting (May 2026)
Shareholder meeting · 23 slides · May 27, 2026
Neuren Pharmaceuticals Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 257 in all · newest Nov 1, 2026 · oldest 2016
- Decks
- 80 decks · latest Sep 2, 2026
Where Neuren Pharmaceuticals Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:NEU · Home listing | ASX | Australia | AUD |
| OTC:NURPF | OTC | United States | USD |
| Frankfurt:NK9 · This page | Frankfurt | Germany | EUR |
| Stuttgart:NK9 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Neuren Pharmaceuticals Limited.